2018
DOI: 10.2147/dmso.s176761
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of bariatric surgery in improving metabolic outcomes in patients with diabetes. A 24-month follow-up study from a single center in the UAE

Abstract: BackgroundOwing to its impact on weight loss, remission of diabetes mellitus and metabolic syndrome, bariatric surgery has offered hope for grossly obese individuals. In recent years, obesity has increased in the UAE and the use of bariatric surgery has increased in-line with this trend. However, data regarding bariatric surgery outcomes in diabetic Emirati people is scarce.ObjectiveTo evaluate the effect of bariatric surgery in patients with diabetes mellitus.MethodsThis is a retrospective analysis of diabeti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…Therefore, moving beyond a weight-centric approach to define the success and the cost-benefit of BS is recommended (Unamuno, Portincasa & Frühbeck, 2019). In a sample of 80 Emirati adults with diabetes, weight loss was within the recommended success rate postoperatively (32% after two years of follow-up); however, patients also experienced significant drops in HbA1c, systolic and diastolic blood pressures, and LDL cholesterol and total cholesterol (p<0.001 for all metabolic markers) (Alnageeb et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, moving beyond a weight-centric approach to define the success and the cost-benefit of BS is recommended (Unamuno, Portincasa & Frühbeck, 2019). In a sample of 80 Emirati adults with diabetes, weight loss was within the recommended success rate postoperatively (32% after two years of follow-up); however, patients also experienced significant drops in HbA1c, systolic and diastolic blood pressures, and LDL cholesterol and total cholesterol (p<0.001 for all metabolic markers) (Alnageeb et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…There was significant reduction in mean body weight at 3, 6, 12, and 24 mo ( P < 0.001 for each time point). Of the 61.3% who had NAFLD, 22.4% showed improvement in sonographic features of hepatic steatosis with normalization of ALT[ 70 ]. In another study ( n = 27) conducted in Saudi Arabia, after 3 mo of bariatric surgery, 66.6% of the patients with preoperative steatosis (median score 2) had reduced steatosis scores postoperatively ( P = 0.025) and 68% of the patients had reduced fibrosis (median score 1) ( P = 0.012).…”
Section: Available Treatment Options For Nonalcoholic Fatty Liver Andmentioning
confidence: 99%